Dr. Tony Walden, MD (he/him) is an Endocrinologist in Concord, NC with over 16 years of experience. What is your opinion of Dr. Tony Walden, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Tony Walden, MD has received over $7,655 which includes payments from the following companies:
$2,235.07 from Medtronic MiniMed, Inc.
$2,132.19 from Merck Sharp & Dohme Corporation
$446.67 from LILLY USA, LLC
$393.20 from Janssen Pharmaceuticals, Inc
$350.37 from AstraZeneca Pharmaceuticals LP
$350.06 from Novo Nordisk Inc
$349.72 from sanofi-aventis U.S. LLC
$165.08 from AKRIMAX PHARMACEUTICALS, LLC
$155.52 from Boehringer Ingelheim Pharmaceuticals, Inc.
$132.54 from AbbVie, Inc.
$116.77 from Amgen Inc.
$108.92 from GlaxoSmithKline, LLC.
$90.17 from Dexcom, Inc.
$76.29 from INSULET CORPORATION
$63.10 from Shire North American Group Inc
$52.63 from Animas Corporation
$49.63 from Valeritas, Inc.
$47.83 from Abbott Laboratories
$40.82 from Takeda Pharmaceuticals America, Inc.
$35.57 from Regeneron Healthcare Solutions, Inc.
Payments received by Dr. Tony Walden, MD were from the following categories:
$4,071.59 Food and Beverage
$1,820.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!